ZA832135B - Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof - Google Patents

Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof

Info

Publication number
ZA832135B
ZA832135B ZA832135A ZA832135A ZA832135B ZA 832135 B ZA832135 B ZA 832135B ZA 832135 A ZA832135 A ZA 832135A ZA 832135 A ZA832135 A ZA 832135A ZA 832135 B ZA832135 B ZA 832135B
Authority
ZA
South Africa
Prior art keywords
preparation
ethers
norscopine
processes
pharmaceutical compositions
Prior art date
Application number
ZA832135A
Other languages
English (en)
Inventor
Rolf Banholzer
Rudolf Dr Bauer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA832135B publication Critical patent/ZA832135B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/08Diarylmethoxy radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
ZA832135A 1982-03-26 1983-03-25 Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof ZA832135B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823211185 DE3211185A1 (de) 1982-03-26 1982-03-26 Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
ZA832135B true ZA832135B (en) 1984-11-28

Family

ID=6159392

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA832135A ZA832135B (en) 1982-03-26 1983-03-25 Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof

Country Status (25)

Country Link
US (1) US4608377A (pt)
EP (1) EP0090195B1 (pt)
JP (1) JPS58174380A (pt)
KR (1) KR900004143B1 (pt)
AT (1) ATE16591T1 (pt)
AU (1) AU554262B2 (pt)
CA (1) CA1254564A (pt)
CS (2) CS236790B2 (pt)
DD (2) DD210276A5 (pt)
DE (2) DE3211185A1 (pt)
DK (1) DK164703C (pt)
ES (2) ES8401971A1 (pt)
FI (1) FI73995C (pt)
GR (1) GR77437B (pt)
HU (1) HU189675B (pt)
IE (1) IE55110B1 (pt)
IL (1) IL68230A0 (pt)
NO (1) NO158741C (pt)
NZ (1) NZ203696A (pt)
PH (1) PH20502A (pt)
PL (1) PL138982B1 (pt)
PT (1) PT76420B (pt)
SU (1) SU1144618A3 (pt)
YU (1) YU42847B (pt)
ZA (1) ZA832135B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3215490A1 (de) * 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neues vorprodukt, verfahren zu seiner herstellung und seine verwendung
DE3215493A1 (de) * 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
SK15382002A3 (sk) * 2000-04-27 2003-03-04 Boehringer Ingelheim Pharma Kg Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie
IL149984A0 (en) * 2000-10-12 2002-12-01 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6852728B2 (en) * 2000-10-14 2005-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7405224B2 (en) * 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7311894B2 (en) * 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
EP1494648B1 (en) * 2002-04-04 2006-09-20 Boehringer Ingelheim Pharma GmbH & Co.KG Powder formulations suitable for inhalation
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
US20080051582A1 (en) * 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1102167B (de) * 1957-09-26 1961-03-16 Sandoz Ag Verfahren zur Herstellung von Scopinaethern
CH476015A (de) * 1965-06-28 1969-07-31 Sandoz Ag Verfahren zur Herstellung neuer Tropanäther
CH582699A5 (pt) * 1973-03-26 1976-12-15 Sandoz Ag

Also Published As

Publication number Publication date
CA1254564A (en) 1989-05-23
FI73995C (fi) 1987-12-10
DD210276A5 (de) 1984-06-06
NO831084L (no) 1983-09-27
PT76420A (de) 1983-04-01
DK94783A (da) 1983-09-27
CS236790B2 (en) 1985-05-15
DD215547A5 (de) 1984-11-14
FI830979L (fi) 1983-09-27
NO158741B (no) 1988-07-18
JPS58174380A (ja) 1983-10-13
EP0090195A1 (de) 1983-10-05
FI830979A0 (fi) 1983-03-23
ATE16591T1 (de) 1985-12-15
ES8402290A1 (es) 1984-01-16
AU554262B2 (en) 1986-08-14
IL68230A0 (en) 1983-06-15
DK164703B (da) 1992-08-03
IE55110B1 (en) 1990-06-06
ES520988A0 (es) 1984-01-01
PT76420B (pt) 1986-02-04
CS410591A3 (en) 1992-06-17
DE3361261D1 (en) 1986-01-02
PL241175A1 (en) 1984-01-30
DK164703C (da) 1992-12-21
AU1286683A (en) 1983-09-29
HU189675B (en) 1986-07-28
JPH0358347B2 (pt) 1991-09-05
YU70783A (en) 1985-12-31
ES520985A0 (es) 1984-01-16
FI73995B (fi) 1987-08-31
ES8401971A1 (es) 1984-01-01
KR900004143B1 (ko) 1990-06-16
EP0090195B1 (de) 1985-11-21
PH20502A (en) 1987-01-21
DK94783D0 (da) 1983-02-25
YU42847B (en) 1988-12-31
NO158741C (no) 1988-10-26
PL138982B1 (en) 1986-11-29
NZ203696A (en) 1985-08-16
US4608377A (en) 1986-08-26
SU1144618A3 (ru) 1985-03-07
IE830671L (en) 1983-09-26
DE3211185A1 (de) 1983-09-29
KR840004106A (ko) 1984-10-06
GR77437B (pt) 1984-09-14

Similar Documents

Publication Publication Date Title
ZA832135B (en) Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof
TW229208B (pt)
GR78442B (pt)
IL64292A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita&#39;,procedimento di preparazione e relative composizioni farmaceutiche.
ZM9283A1 (en) Substituted phenylsulfonyloxybenzimidazolecarbamates,processes for their preparation and pharmaceutical compositions containing the same
ZA792042B (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
EP0107693A4 (de) 2,3,4-trinor-1,5-inter-m-phenylen-prostacyclin-i2-analoge, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische präparate.
GR73033B (pt)
IL59987A0 (en) 3-substituted-tetrahydro-pyrrolo(1,2-a)pyrimidines,process for the preparation thereof and pharmaceutical compositions containing them
IL60026A0 (en) 3-substituted-hexahydro-pyrimido(1,2-a azepins,process for the preparation thereof and pharmaceutical compositions containing the same
DE3166701D1 (en) 3-amino-5-substituted-6-halo-n-(3,4-dihydro- or 4,4-disubstituted-6-substituted-1,3,5-triazin-2-yl)-2-pyrazinecarboxamides, process for preparing and pharmaceutical compositions containing the same
SG88994G (en) Process for the preparation of anti-oxidant compositions.
IL61421A0 (en) 7-oxo-pgi2-derivatives, process for the preparation thereof and pharmaceutical compositions containing same